- Home
- MGRX vs SHPH Comparison
MGRX vs SHPH Comparison
Compare MGRX & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRX
- SHPH
- Stock Information
- Founded
- MGRX 2021
- SHPH 2012
- Country
- MGRX United States
- SHPH United States
- Employees
- MGRX N/A
- SHPH N/A
- Industry
- MGRX Computer Software: Prepackaged Software
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- MGRX Technology
- SHPH Health Care
- Exchange
- MGRX Nasdaq
- SHPH Nasdaq
- Market Cap
- MGRX 7.0M
- SHPH 3.3M
- IPO Year
- MGRX 2023
- SHPH 2022
- Fundamental
- Price
- MGRX $2.50
- SHPH $1.41
- Analyst Decision
- MGRX
- SHPH
- Analyst Count
- MGRX 0
- SHPH 0
- Target Price
- MGRX N/A
- SHPH N/A
- AVG Volume (30 Days)
- MGRX 1.0M
- SHPH 43.1K
- Earning Date
- MGRX 10-29-2024
- SHPH 11-12-2024
- Dividend Yield
- MGRX N/A
- SHPH N/A
- EPS Growth
- MGRX N/A
- SHPH N/A
- EPS
- MGRX N/A
- SHPH N/A
- Revenue
- MGRX $866,792.00
- SHPH N/A
- Revenue This Year
- MGRX N/A
- SHPH N/A
- Revenue Next Year
- MGRX N/A
- SHPH N/A
- P/E Ratio
- MGRX N/A
- SHPH N/A
- Revenue Growth
- MGRX 245.48
- SHPH N/A
- 52 Week Low
- MGRX $2.15
- SHPH $1.03
- 52 Week High
- MGRX $16.80
- SHPH $4.94
- Technical
- Relative Strength Index (RSI)
- MGRX 32.69
- SHPH 49.84
- Support Level
- MGRX $2.20
- SHPH $1.12
- Resistance Level
- MGRX $2.83
- SHPH $1.26
- Average True Range (ATR)
- MGRX 0.41
- SHPH 0.11
- MACD
- MGRX -0.06
- SHPH 0.06
- Stochastic Oscillator
- MGRX 8.44
- SHPH 68.09
About MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.